Acumen Pharmaceuticals Inc (ABOS)
Earnings
Annual and quarterly EPS data presented alongside analyst estimates, earnings surprises, and historical growth statistics. The side-by-side view of reported versus estimated EPS — combined with surprise percentage and report timing — allows investors to assess whether a company consistently beats, meets, or misses market expectations, and how that track record has evolved across full economic cycles.
Earnings annual
Fiscal date endingReported EPS
Dec 31, 2019
-4.8781
Dec 31, 2020
-64.3985
Dec 31, 2021
-9.37
Dec 31, 2022
-1.06
Dec 31, 2023
-1.08
Dec 31, 2024
-1.71
Dec 31, 2025
-2.01
Mar 31, 2026
-0.328
Jun 30, 2026
-0.78
Calculation
Growth rate
20.48%
Average
-9.513
Maximum
Mar 31, 2026
-0.328
Minimum
Dec 31, 2020
-64.3985
Median
Dec 31, 2024
-1.71
Earnings quarterly
| Fiscal date ending | Dec 31, 2019 |
| Reported date | Mar 30, 2020 |
| Report time | PRE_MARKET |
| Reported EPS | -4.8781 |
| Estimated EPS | 0 |
| Surprise | -4.8781 |
| Surprise (%) | % |
| Fiscal date ending | Dec 31, 2020 |
| Reported date | Mar 31, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -64.3985 |
| Estimated EPS | 0 |
| Surprise | -64.3985 |
| Surprise (%) | % |
| Fiscal date ending | Mar 31, 2021 |
| Reported date | Jun 2, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.94 |
| Estimated EPS | -0.94 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Jun 30, 2021 |
| Reported date | Jul 2, 2021 |
| Report time | POST_MARKET |
| Reported EPS | -7.91 |
| Estimated EPS | -6.72 |
| Surprise | -1.19 |
| Surprise (%) | -17.7083% |
| Fiscal date ending | Sep 30, 2021 |
| Reported date | Nov 15, 2021 |
| Report time | PRE_MARKET |
| Reported EPS | -0.1 |
| Estimated EPS | -0.15 |
| Surprise | 0.05 |
| Surprise (%) | 33.3333% |
| Fiscal date ending | Dec 31, 2021 |
| Reported date | Mar 28, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.42 |
| Estimated EPS | -0.14 |
| Surprise | -0.28 |
| Surprise (%) | -200% |
| Fiscal date ending | Mar 31, 2022 |
| Reported date | May 16, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.23 |
| Estimated EPS | -0.17 |
| Surprise | -0.06 |
| Surprise (%) | -35.2941% |
| Fiscal date ending | Jun 30, 2022 |
| Reported date | Aug 15, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.25 |
| Estimated EPS | -0.25 |
| Surprise | 0 |
| Surprise (%) | 0% |
| Fiscal date ending | Sep 30, 2022 |
| Reported date | Nov 14, 2022 |
| Report time | POST_MARKET |
| Reported EPS | -0.26 |
| Estimated EPS | -0.2 |
| Surprise | -0.06 |
| Surprise (%) | -30% |
| Fiscal date ending | Dec 31, 2022 |
| Reported date | Mar 27, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.32 |
| Estimated EPS | -0.25 |
| Surprise | -0.07 |
| Surprise (%) | -28% |
| Fiscal date ending | Mar 31, 2023 |
| Reported date | May 9, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.28 |
| Estimated EPS | -0.33 |
| Surprise | 0.05 |
| Surprise (%) | 15.1515% |
| Fiscal date ending | Jun 30, 2023 |
| Reported date | Aug 8, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.28 |
| Estimated EPS | -0.34 |
| Surprise | 0.06 |
| Surprise (%) | 17.6471% |
| Fiscal date ending | Sep 30, 2023 |
| Reported date | Nov 13, 2023 |
| Report time | PRE_MARKET |
| Reported EPS | -0.24 |
| Estimated EPS | -0.26 |
| Surprise | 0.02 |
| Surprise (%) | 7.6923% |
| Fiscal date ending | Dec 31, 2023 |
| Reported date | Mar 26, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.28 |
| Estimated EPS | -0.26 |
| Surprise | -0.02 |
| Surprise (%) | -7.6923% |
| Fiscal date ending | Mar 31, 2024 |
| Reported date | May 14, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.25 |
| Estimated EPS | -0.23 |
| Surprise | -0.02 |
| Surprise (%) | -8.6957% |
| Fiscal date ending | Jun 30, 2024 |
| Reported date | Aug 13, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.34 |
| Estimated EPS | -0.25 |
| Surprise | -0.09 |
| Surprise (%) | -36% |
| Fiscal date ending | Sep 30, 2024 |
| Reported date | Nov 12, 2024 |
| Report time | PRE_MARKET |
| Reported EPS | -0.5 |
| Estimated EPS | -0.3 |
| Surprise | -0.2 |
| Surprise (%) | -66.6667% |
| Fiscal date ending | Dec 31, 2024 |
| Reported date | Mar 27, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.62 |
| Estimated EPS | -0.3658 |
| Surprise | -0.2542 |
| Surprise (%) | -69.4915% |
| Fiscal date ending | Mar 31, 2025 |
| Reported date | May 13, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.48 |
| Estimated EPS | -0.55 |
| Surprise | 0.07 |
| Surprise (%) | 12.7273% |
| Fiscal date ending | Jun 30, 2025 |
| Reported date | Aug 12, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.68 |
| Estimated EPS | -0.52 |
| Surprise | -0.16 |
| Surprise (%) | -30.7692% |
| Fiscal date ending | Sep 30, 2025 |
| Reported date | Nov 12, 2025 |
| Report time | PRE_MARKET |
| Reported EPS | -0.44 |
| Estimated EPS | -0.68 |
| Surprise | 0.24 |
| Surprise (%) | 35.2941% |
| Fiscal date ending | Dec 31, 2025 |
| Reported date | Mar 26, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.41 |
| Estimated EPS | -0.4558 |
| Surprise | 0.0458 |
| Surprise (%) | 10.0483% |
| Fiscal date ending | Mar 31, 2026 |
| Reported date | May 12, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.33 |
| Estimated EPS | -0.46 |
| Surprise | 0.13 |
| Surprise (%) | 28.2609% |
| Fiscal date ending | Jun 30, 2026 |
| Reported date | Aug 11, 2026 |
| Report time | PRE_MARKET |
| Reported EPS | -0.45 |
| Estimated EPS | -0.39 |
| Surprise | -0.06 |
| Surprise (%) | -15.3846% |
Calculation
Growth rate
9.84%
Average
-3.554
Maximum
Sep 30, 2021
-0.1
Minimum
Dec 31, 2020
-64.3985
Median
Dec 31, 2025
-0.41